EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy

Jie Liu, Shizhao Zhou, Yingying Wei, Jinglei Du iD, Fan Jia, Wenhui Dong, Yangyi Cao, Zhenyang Shi, Hongkai Mu, Lin Chen, Shiping Yu iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s535455 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Jie Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Imaging Department, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms, Drug Resistance, Neoplasm. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibCarcinoma, HepatocellularLiver NeoplasmsDrug Resistance, NeoplasmNanocompositesAntineoplastic AgentsHumansTumor MicroenvironmentAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

combination therapiesdrug deliverydrug resistancehepatocellular carcinomananocompositesnanomedicinenanoparticlessorafenib

Substanzen

SorafenibAntineoplastic Agents

Autor:innen und Institutionen

  • Medical Imaging Department, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
  • Department of Interventional Therapy, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan…
  • Affiliated Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
  • Department of Oncology and Vascular Intervention, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
  • Academy of Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
  • Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, Shanxi, 030024, People's Republic of China.

ORCID-Profile: Jinglei Du, Shiping Yu

Zitieren

APA

Liu, J., Zhou, S., Wei, Y., Du, J., Jia, F., Dong, W., Cao, Y., Shi, Z., Mu, H., Chen, L., & Yu, S. (2025). Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s535455

Vancouver

Liu J, Zhou S, Wei Y, Du J, Jia F, Dong W, et al. Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s535455

BibTeX
@article{Liu2025,
  author = {Liu, Jie and Zhou, Shizhao and Wei, Yingying and Du, Jinglei and Jia, Fan and Dong, Wenhui and Cao, Yangyi and Shi, Zhenyang and Mu, Hongkai and Chen, Lin and Yu, Shiping},
  title = {Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s535455}
}
Kostenlos starten →